768 Effect of PSA response on overall and progression-free survival in patients with metastatic castration resistant prostate cancer (mCRPC) treated with cabazitaxel (Caba): The non-interventional study QoLiTime
Authors:
- P. HammererPHP. Hammerer
- S-E. Al-BatranSAS-E. Al-Batran
- C. Windemuth-KieselbachCWC. Windemuth-Kieselbach
- R-D. HofheinzRHR-D. Hofheinz
- 1 March 2016
- journal article
- Published by Elsevier in European Urology Supplements
- Vol. 15 (3) , e768